食管癌切除术后新食管-气道瘘的治疗:系统文献综述与Meta分析
该系统综述与Meta分析纳入17项病例系列研究共302例新食管-气道瘘患者,比较仅非手术治疗、直接手术及非手术后手术三种策略。非手术准备后手术的1年治疗后死亡率为33%(95%CI 0.17-0.48),低于仅非手术的68%(95%CI 0.39-0.97)和直接手术的67%(95%CI 0.36-0.98);口服进食恢复与瘘复发在各策略间无显著差异。
要点
- 非手术准备后手术的1年治疗后死亡率为33%,低于仅非手术的68%和直接手术的67%。
- 瘘位置与1年死亡率无关,口服进食恢复和瘘复发在各治疗策略间无显著差异。
- 作者认为非手术准备后手术可能提供最高1年生存率,但患者选择标准可能影响结果。
核心结论
- 非手术准备后手术可能为NEAF患者提供最高的1年生存率,但患者选择标准可能影响本研究发现。
研究设计与样本
- 系统检索PubMed、EMBASE和Web of Science英文文献,纳入报告NEAF治疗与生存的病例系列研究。
- 共鉴定177项研究,排除62项重复、95项不相关及全文审查后3项未报告1年生存的研究。
- 排除标准包括仅摘要、恶性NEAF、无食管切除与食管胃吻合、患者少于5例及NEAF非研究主要焦点。
- 最终纳入17项研究共302例患者,数据提取遵循MOOSE指南,采用随机效应模型合并数据。
主要发现
- 非手术准备后手术的1年治疗后死亡率为33%(95%CI 0.17-0.48),低于仅非手术的68%(95%CI 0.39-0.97)和直接手术的67%(95%CI 0.36-0.98)。
- 瘘位置与1年死亡率无关。
- 口服进食恢复和瘘复发在各治疗策略间无显著差异。
临床怎么用
- 原文结论认为非手术准备后手术可能提供最高的1年生存率,但患者选择标准可能影响结果。
局限性
- 患者选择标准可能影响了本研究的发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Neo-oesophageal-airway fistula (NEAF) between gastric conduit and airway is a rare but life-threatening complication of oesophagectomy for oesophageal cancer. Optimal treatment remains unknown. A meta-analysis of good-quality case series may help determine whether nonoperative management (NOM) only, upfront surgery (S), or NOM followed by surgery is associated with better 1-year post-treatment mortality, resumption of oral diet and fistula recurrence. METHODS: We systematically searched PubMed, EMBASE and Web of Science for publications in English reporting case series of management and survival in patients with NEAF. Of the 177 identified studies, 62 were duplicates and 95 were not relevant to our topic. Three studies were excluded after a full-text review, due to absence of reporting of 1-year survival. Exclusion criteria to identified publications were: abstract only, malignant NEAF, absence of oesophagectomy and esogastric anastomosis, fewer than 5 patients and NEAF not the main focus of the study. Data-extraction was conducted in accordance with MOOSE guidelines. Data were pooled using random-effects model. RESULTS: Seventeen studies (302 patients) were included. One-year post-treatment mortality was considerably lower with NOM followed by surgery [33%; 95% confidence interval (CI), 0.17-0.48] than with NOM (68%; 95% CI, 0.39-0.97) or S (67%; 95% CI, 0.36-0.98). Fistula location was not associated with 1-year mortality. Neither resumption of an oral diet nor fistula recurrence differed significantly across treatment strategies. CONCLUSIONS: NOM to prepare patients for surgery followed by surgical repair may provide the highest 1-year survival of patients with NEAF. However, patient selection criteria to each of 3 treatment strategies may have affected our findings.
引用
- Bertrand T, Chatellier G, Mercier O, et al. Management of neo-esophagus-airway fistula after esophagectomy for oesophageal cancer: systematic literature review and meta-analysis. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38814807. doi:10.1093/icvts/ivae110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。